North America Analysis
Home Search

Stem cell gene therapy - search results

If you're not happy with the results, please do another search
oncolytic virus, fraunhofer institute

TheraVision: An oncolytic virus platform technology for a personalised virus-immunotherapy

Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.
brittle bone disease, exosome therapy

Exosome therapy for brittle bone disease

Pascale V Guillot, Associate Professor at University College London, investigates the possibility of exosome therapy for those living with brittle bone disease.

Third known case of HIV remission after stem cell transplant

After receiving a cord blood stem cell transplant to treat acute myeloid leukaemia a woman with diagnosed HIV has had no detectable levels of HIV for 14 months
metastatic breast cancer

Prospects for minimally invasive and optimally effective cancer immunotherapy

Here, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, Peter Betscher, explains how he is dedicated towards realising Robert North’s vision.
metastatic breast cancer, immunotherapy

Scientists use tumour-fighting cells to treat breast cancer

An ongoing clinical trial led by the NCI Centre for Cancer Research reveals an experimental form of immunotherapy for metastatic breast cancer.
sickle cell anaemia

£2.3 million awarded to York University for sickle cell anaemia research

The Bill & Melinda Gates foundation have awarded £2.3million to the University of York, in attempt to push research into sickle cell anaemia.
brain tumour patients

Getting personal in brain tumour therapy: Matching therapies to patients

Sean E. Lawler PhD from Brown University Cancer Center, an experienced scientist in the brain tumour field
creatine deficiency, genetic treatment

Genetic disease treatment research for creatine deficiency

Professor Olivier Braissant, believes there is hope for the treatment of creatine deficiency thanks to new genetic disease research - here, he tells us all about the recent developments.
therapy eye diseases, I27-breg

NIH discover new potential therapy for eye diseases

A new study shows promise for future therapies for blinding eye diseases, uveitis and multiple sclerosis.
regenerative medicine, medicine

Australia’s medical innovation approach: Is it suitable for regenerative medicine?

Australia has committed to investing heavily in its medical future – but will it be ready for the regenerative medicine revolution? John Gardner from Monash University and Michael Morrison from the University of Oxford provide the answer.
stem cells

Stem cell therapy to treat brittle bone disease

Pascale V Guillot from Elizabeth Garrett Anderson Institute for Women’s Health, provides further analysis of stem cell therapy for brittle bone disease
miRNAs in brain cancer therapy

miRNAs in brain cancer therapy – Mighty things from small beginnings grow

Dr Hernando Lopez-Bertoni at the Department of Neurology, Johns Hopkins School of medicine, discusses the development of miRNAs in brain cancer therapy
hormone replacement therapy (HRT)

Type-2 diabetes and hormone replacement therapy (HRT)

Dr Deborah Lee, Dr Fox Online Pharmacy, discusses the link between menopause and type-2 diabetes, as well as the use of hormone replacement therapy (HRT) in diabetic perimenopausal women Doctors have been reluctant in the past, to prescribe hormone replacement therapy (HRT) for perimenopausal women with type-2 diabetes (T2DM). This...
osteogenesis imperfecta (OI)

Osteogenesis imperfecta – what we need to know

Frost & Sullivan’s TechCasting Group, places the spotlight on osteogenesis imperfecta – toward future targeted, more effective therapy.
regenerative medicine, regenerative

Japan: A case study of national “readiness” for regenerative medicine

This article focuses on Japan, as a country with a strong and distinctive strategy for delivering RM, and outlines efforts to build regenerative readiness.
regenerative cell therapeutics

The future of regenerative cell therapeutics

Tobias Deuse, Cardiac Surgeon and Scientist at University of California San Francisco, reveals to us the future of regenerative cell therapeutics.
gene therapy field

What are the challenges surrounding gene therapy today?

Dr Jen Vanderhoven, Director, National Horizons Centre, Teesside University, sheds some light on how the gene therapy field can progress in the face of funding challenges and skills shortages.
restore eyesight, gene therapy

Scientists successfully use gene therapy to restore eyesight 

Scientists in France have partially restored the eyesight of a blind man, using gene therapy - he is now able to identify blurry shapes.
treating genetic diseases

Today’s challenge of treating genetic diseases

Professor Olivier Braissant highlights here, how the challenges of treating genetic diseases can be exemplified by research on creatine transporter deficiency.
insulin to immunotherapy

From insulin to immunotherapy: A century of discovery

Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.

Follow Open Access Government